THN391

DRUG2 trials

Sponsors

Therini Bio Pty Ltd, Therini Bio, Inc.

Conditions

Alzheimer Disease, Early OnsetDiabetic Macular EdemaDiabetic Retinopathy

Phase 1

A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

RecruitingNCT06701721

Therini Bio Pty LtdDiabetic Macular Edema, Diabetic Retinopathy

Start: 2024-12-20End: 2027-05-31Target: 21Updated: 2026-07-02

A Study to Assess THN391 in Subjects With Alzheimer's Disease

Active, not recruitingNCT06814730

Therini Bio, Inc.Alzheimer Disease, Early Onset

Start: 2025-07-17End: 2027-05-31Updated: 2026-07-08